Transglutaminase 2 as a therapeutic target for neurological conditions.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on therapeutic targets"
DOI: 10.1080/14728222.2021.1989410
Abstract: INTRODUCTION : Transglutaminase 2 (TG2) has been implicated in numerous neurological conditions, including neurodegenerative diseases, multiple sclerosis, and CNS injury. Early studies on the role of TG2 in neurodegenerative conditions focused on its ability to… read more here.
Keywords: tg2; tg2 inhibitors; neurodegenerative diseases; sclerosis cns ... See more keywords